col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


88 Ergebisse       Seite 1

 [1] 
Future Medicine: Future Microbiology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jan―09 Statement of Retraction: Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
2 [GO] 2024―Aug―07 COVID-19: did the masks work? Roy D Sleator, Niall Smith
3 [GO] 2024―Jul―04 Letter to the editor: before molecules are claimed as biomarkers of COVID-19, their criteria must be met Josef Finsterer
4 [GO] 2024―Jun―24 Letter in reply: before biomolecules are claimed as biomarkers of COVID-19, their criteria must be met Murat Karamese
5 [GO] 2024―Jun―24 Clostridioides difficile infection epidemiology during the COVID-19 pandemic in Greece Theodoros Karampatakis, Eleni Kandilioti, Helen Katsifa, Anna Nikopoulou, Celine Harmanus, Katerina Tsergouli, et al. (+2)
6 [GO] 2024―Mai―31 Severe mold fungal infections in critically ill patients with COVID-19 Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, et al. (+3)
7 [GO] 2024―Mai―23 Online dashboards for SARS-CoV-2 wastewater-based epidemiology Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
8 [GO] 2024―Apr―17 JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants Soumya Basu, Titirsha Kayal, Ponoop Prasad Patro, Amit Patnaik
9 [GO] 2024―Jan―31 Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, et al. (+3)
10 [GO] 2024―Jan―31 Triple in silico targeting of IMPDH enzyme and RNA-dependent RNA polymerase of both SARS-CoV-2 and Rhizopus oryzae Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary
11 [GO] 2023―Nov―01 Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients Murat Karamese, Abdullah Gumus, Eray Atalay, Emin E Tutuncu
12 [GO] 2023―Okt―20 Plain language summary: Did the COVID-19 pandemic change the resistance to current antifungal medicines? Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira
13 [GO] 2023―Okt―18 Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico Jorge A Rangel-Méndez, Luciola Jaimes-Gurrusquieta, Juan F Sánchez-Cruz, Ma I Zarate-Murillo, Jessica Domínguez-Méndez, Hugo A Laviada-Molina, et al. (+2)
14 [GO] 2023―Sep―26 Has coronavirus disease 2019 changed clinical microbiology laboratories forever? Joseph M Blondeau, Jennifer Coetzee
15 [GO] 2023―Sep―05 Pandemic predictions and precautionary preparations: lessons from history Thomas H Pennington
16 [GO] 2023―Jul―14 Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals Maria LS Pereira, Davi AC Mothé, Kézia S Pinheiro, Sarah S Gonçalves, Kênia V Santos
17 [GO] 2023―Mrz―14 Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, et al. (+17)
18 [GO] 2023―Jan―17 Mucormycosis in the COVID-19 scenario beyond hospitalized patients Alexandro Bonifaz, Andrés Tirado-Sánchez, Javier Araiza, María Luisa Hernández-Medel
19 [GO] 2022―Okt―06 Acinetobacter baumannii infections resistant to treatment: warning signs from the COVID-19 pandemic Ryan C Ellis, Elena K Roberts, Jennifer T Grier, Steven E Fiester
20 [GO] 2022―Sep―28 Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Filiz Pehlivanoglu, Gonul Sengoz
21 [GO] 2022―Sep―16 Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21 Lucyana LC Coutinho, Caroline N Oliveira, Polianna LMM Albuquerque, Sandra MB Mota, Gdayllon C Meneses, Alice MC Martins, et al. (+6)
22 [GO] 2022―Sep―16 Comment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’ Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García, Javier Mancilla-Galindo
23 [GO] 2022―Aug―04 Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection Atalay Eray, Karamese Murat, Gumus Abdullah, Kahraman Ihsan, Kelesoglu Royca, Ozgur Didem, Tutuncu E Ediz
24 [GO] 2022―Jul―28 Role of the PD-1 and PD-L1 axis in COVID-19 Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry
25 [GO] 2022―Jul―28 First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria Denis Niyazi, Borislava Toncheva, Tsvetan Tonchev, Deyan Dzhenkov, Kalin Kalchev, Temenuga Stoeva
26 [GO] 2022―Jul―28 Coinfection with Strongyloides and Ascaris in a COVID-19-positive male presenting with acute abdomen: a case report Sweta Singh, Uday S Singh
27 [GO] 2022―Jul―28 SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian
28 [GO] 2022―Jul―26 G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19 Abir Mondal, Soumyadeep Mukherjee, Waseem Dar, Prince Upadhyay, Anand Ranganathan, Soumya Pati, Shailja Singh
29 [GO] 2022―Jul―26 Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha Tjaša Ž Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, et al. (+9)
30 [GO] 2022―Mai―05 Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? Sheila Santa, Derek A Doku, Charles O Olwal, Charles A Brown, Emmanuel A Tagoe, Osbourne Quaye
31 [GO] 2022―Mai―05 Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective Abdo A Elfiky
32 [GO] 2022―Apr―25 Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19 Malihe Naderi, Seyed Amir Soltani, Akram Taheri Rad, Zahra Mehrbakhsh, Sina Sodagar, Alireza Tahamtan, Seyedeh Sedigheh Hosseini
33 [GO] 2022―Apr―20 Clostridioides difficile co-infection in patients with COVID-19 Roman Maslennikov, Vladimir Ivashkin, Anna Ufimtseva, Elena Poluektova, Anatoly Ulyanin
34 [GO] 2022―Apr―01 Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children Danilo Buonsenso, Ferran Espuny Pujol, Daniel Munblit, Davide Pata, Sammie McFarland, Frances K Simpson
35 [GO] 2022―Mrz―30 Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2 Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, Sundararaj S Jeremiah, Michiharu Kudo, Akihide Ryo
36 [GO] 2022―Mrz―14 Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis Kevin Bouiller, Nathan Peiffer-Smadja, Muge Cevik, Katharina Last, Ivana A Antunović, Anja Šterbenc, et al. (+4)
37 [GO] 2022―Mrz―14 Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest Abdullah Al Saba, Maisha Adiba, Sajib Chakraborty, AHM Nurun Nabi
38 [GO] 2022―Feb―24 Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki
39 [GO] 2022―Feb―15 Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall
40 [GO] 2022―Feb―09 Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody
41 [GO] 2022―Jan―19 Scrub typhus in two COVID-19 patients: a diagnostic dilemma Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, et al. (+5)
42 [GO] 2022―Jan―19 Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank Michael Frank
43 [GO] 2021―Dez―17 Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, et al. (+5)
44 [GO] 2021―Dez―17 Inflammation at the crossroads of Helicobacter pylori and COVID-19 Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas
45 [GO] 2021―Nov―23 Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, et al. (+7)
46 [GO] 2021―Nov―23 Drug-based therapeutic strategies for COVID-19-infected patients and their challenges Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, et al. (+5)
47 [GO] 2021―Nov―11 Current status of therapeutic approaches and vaccines for SARS-CoV-2 Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees
48 [GO] 2021―Nov―10 Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult
49 [GO] 2021―Okt―25 Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, et al. (+4)
50 [GO] 2021―Okt―22 A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya
51 [GO] 2021―Okt―07 Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey Murat Karamese, Didem Ozgur, Emin E Tutuncu
52 [GO] 2021―Sep―01 Coronaviruses construct an interconnection way with ERAD and autophagy Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour
53 [GO] 2021―Sep―01 SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, et al. (+8)
54 [GO] 2021―Jul―28 Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok
55 [GO] 2021―Jul―28 Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi
56 [GO] 2021―Jul―05 Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, et al. (+7)
57 [GO] 2021―Jun―24 Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni
58 [GO] 2021―Jun―04 Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau Joseph Blondeau
59 [GO] 2021―Mai―17 Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez Peter Hotez
60 [GO] 2021―Mai―11 Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response Xin Chen, Mingli Gu, Tengda Li, Yi Sun
61 [GO] 2021―Mai―07 Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris
62 [GO] 2021―Apr―13 Herd immunity: could it bring the COVID-19 pandemic to an end? Thomas Hugh Pennington
63 [GO] 2021―Apr―13 The interplay of SARS-CoV-2 and Clostridioides difficile infection Sahil Khanna, Colleen S Kraft
64 [GO] 2021―Mrz―12 COVID-19 pneumonia: do not leave the corticosteroids behind! Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa
65 [GO] 2021―Feb―11 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
66 [GO] 2021―Jan―25 COVID-19: it is all about sepsis Jean-Louis Vincent
67 [GO] 2021―Jan―19 Review of the use of nasal and oral antiseptics during a global pandemic Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar
68 [GO] 2021―Jan―18 The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 Mayra Cuéllar-Cruz
69 [GO] 2021―Jan―06 Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, et al. (+2)
70 [GO] 2021―Jan―06 Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye
71 [GO] 2020―Dez―22 COVID-19: mask efficacy is dependent on both fabric and fit Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, et al. (+3)
72 [GO] 2020―Nov―24 Chloroquine/hydroxycloroquine and COVID-19: need to know more about Antonio Cassone, Licia Iacoviello, Roberto Cauda
73 [GO] 2020―Nov―20 The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic Lígia N de M Ribeiro, Belchiolina B Fonseca
74 [GO] 2020―Nov―12 Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, et al. (+7)
75 [GO] 2020―Nov―06 Clinical microbiology laboratories and COVID-19: the calm before the storm Joseph M Blondeau
76 [GO] 2020―Nov―06 Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation Michael B Yakass, Osbourne Quaye, Bryan J Woodward
77 [GO] 2020―Nov―03 Coronavirus pandemic: treatment and future prevention Kenneth Lundstrom
78 [GO] 2020―Okt―21 Systemic mycoses: a potential alert for complications in COVID-19 patients Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases
79 [GO] 2020―Okt―21 Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
80 [GO] 2020―Sep―21 Potential alteration of COVID-19 by beta-mercaptoethanol Robert E Click
81 [GO] 2020―Sep―03 SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris
82 [GO] 2020―Aug―27 Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh
83 [GO] 2020―Aug―26 Phages in the fight against COVID-19? Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski
84 [GO] 2020―Aug―14 Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, et al. (+3)
85 [GO] 2020―Jul―17 COVID-19: in the absence of vaccination - ‘mask-the-nation’ Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith
86 [GO] 2020―Jul―14 N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester
87 [GO] 2020―Jul―08 The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani
88 [GO] 2020―Jun―11 Focus on a 2019-novel coronavirus (SARS-CoV-2) Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang
 [1] 

88 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec